| pubmed-article:8111666 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:8111666 | lifeskim:mentions | umls-concept:C0031809 | lld:lifeskim |
| pubmed-article:8111666 | lifeskim:mentions | umls-concept:C1280551 | lld:lifeskim |
| pubmed-article:8111666 | lifeskim:mentions | umls-concept:C0006772 | lld:lifeskim |
| pubmed-article:8111666 | lifeskim:mentions | umls-concept:C0035126 | lld:lifeskim |
| pubmed-article:8111666 | lifeskim:mentions | umls-concept:C0151814 | lld:lifeskim |
| pubmed-article:8111666 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:8111666 | lifeskim:mentions | umls-concept:C0205178 | lld:lifeskim |
| pubmed-article:8111666 | lifeskim:mentions | umls-concept:C0243077 | lld:lifeskim |
| pubmed-article:8111666 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:8111666 | pubmed:dateCreated | 1994-3-31 | lld:pubmed |
| pubmed-article:8111666 | pubmed:abstractText | To re-evaluate the suitability of chlorpromazine and trifluoperazine to prevent postischemic reperfusion injury of the myocardium. | lld:pubmed |
| pubmed-article:8111666 | pubmed:language | eng | lld:pubmed |
| pubmed-article:8111666 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8111666 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:8111666 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8111666 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8111666 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8111666 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:8111666 | pubmed:issn | 0828-282X | lld:pubmed |
| pubmed-article:8111666 | pubmed:author | pubmed-author:StykJJ | lld:pubmed |
| pubmed-article:8111666 | pubmed:author | pubmed-author:GabauerII | lld:pubmed |
| pubmed-article:8111666 | pubmed:author | pubmed-author:ZiegelhöfferA... | lld:pubmed |
| pubmed-article:8111666 | pubmed:author | pubmed-author:SlezakJJ | lld:pubmed |
| pubmed-article:8111666 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:8111666 | pubmed:volume | 10 | lld:pubmed |
| pubmed-article:8111666 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:8111666 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:8111666 | pubmed:pagination | 125-32 | lld:pubmed |
| pubmed-article:8111666 | pubmed:dateRevised | 2008-4-9 | lld:pubmed |
| pubmed-article:8111666 | pubmed:meshHeading | pubmed-meshheading:8111666-... | lld:pubmed |
| pubmed-article:8111666 | pubmed:meshHeading | pubmed-meshheading:8111666-... | lld:pubmed |
| pubmed-article:8111666 | pubmed:meshHeading | pubmed-meshheading:8111666-... | lld:pubmed |
| pubmed-article:8111666 | pubmed:meshHeading | pubmed-meshheading:8111666-... | lld:pubmed |
| pubmed-article:8111666 | pubmed:meshHeading | pubmed-meshheading:8111666-... | lld:pubmed |
| pubmed-article:8111666 | pubmed:meshHeading | pubmed-meshheading:8111666-... | lld:pubmed |
| pubmed-article:8111666 | pubmed:meshHeading | pubmed-meshheading:8111666-... | lld:pubmed |
| pubmed-article:8111666 | pubmed:meshHeading | pubmed-meshheading:8111666-... | lld:pubmed |
| pubmed-article:8111666 | pubmed:meshHeading | pubmed-meshheading:8111666-... | lld:pubmed |
| pubmed-article:8111666 | pubmed:articleTitle | Further assessment of the protective effect of calmodulin inhibitors against reperfusion injury after acute coronary occlusion in the dog. | lld:pubmed |
| pubmed-article:8111666 | pubmed:affiliation | Institute for Heart Research, Slovak Academy of Sciences, Braislava. | lld:pubmed |
| pubmed-article:8111666 | pubmed:publicationType | Journal Article | lld:pubmed |
